1. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cellsDamjan Avsec, Alma Tana Jakoš Djordjevič, Maša Kandušer, Helena Podgornik, Matevž Škerget, Irena Mlinarič-Raščan, 2021, original scientific article Keywords: chronic lymphocytic leukemia, autophagy, AMPK/ULK1, venetoclax, drug resistance, targeted therapy
Full text (file, 5,50 MB) This document has more files! More... |
2. High burden of clonal mast cell disorders and hereditary α-tryptasemia in patients who need Hymenoptera venom immunotherapyPeter Korošec, Gunter J. Sturm, Jonathan J. Lyons, Tinkara Pirc Marolt, Manca Svetina, Mitja Košnik, Mihaela Zidarn, Mark Kačar, Nina Frelih, Nika Lalek, Ajda Demšar Luzar, Samo Zver, Matevž Škerget, Ewa Czarnobilska, Wojciech Dyga, Sanja Popović-Grle, Miroslav Samaržija, Lisa Arzt-Gradwohl, Urban Čerpes, Grzegorz Porebski, Branko Pevec, Eva Schadelbauer, Peter Kopač, Julij Šelb, Matija Rijavec, 2024, original scientific article Keywords: anaphylaxis, hereditary α-tryptasemia, hypersensitivity, immunotherapy, mast cell, mastocytosis, venom
Full text (file, 7,47 MB) This document has more files! More... |
3. Vpliv mobilizacije na repopulacijo limfocitov po avtologni presaditvi krvotvornih matičnih celic pri bolnikih z diseminiranim plazmocitomomMatevž Škerget, 2016, doctoral dissertation Keywords: hematologija, presaditev hematopoetskih matičnih celic, avtologna presaditev, diseminirani plazmocitom, štetje limfocitov, pretočna citometrija, mobilizacija hematopoetskih matičnih celic
Full text (file, 1,41 MB) |
4. An unforeseen realityAnka Blagotinšek Ošep, Eva Brecl, Matevž Škerget, Lina Savšek, 2023, other scientific articles Keywords: multiple sclerosis, alemtuzumab, hemophagocytic lymphohistiocytosis, side effects, neuroimmunology, drug therapy, adverse effects
Full text (file, 1,18 MB) This document has more files! More... |
|
|
